Tesamorelin completed Phase III clinical trials for HIV-associated lipodystrophy and received FDA approval in 2010 based on efficacy data showing 1518% reductions in visceral adipose tissue over 26 weeks
That same person using Tirzepatide would lose about 46 pounds, and using Semaglutide would lose approximately 33 pounds
see tirzepatide maintenance dose after weight loss for the comparable strategy
Taken together, the figure highlights a key mechanistic principle underlying the therapeutic rationale for multi-agonist strategies: while GLP-1R monotherapy achieves meaningful metabolic and hepatic benefits exclusively through indirect, systemic pathways, the addition of GIPR and - most importantly - GCGR co-agonism introduces complementary and increasingly direct hepatic mechanisms, providing the pharmacological basis for the superior efficacy observed with dual and triple agonists in MASLD/MASH
You can repeat this medically supervised weight loss plan as many times as you wish
Choose Nutrient Dense Foods We shift the focus from volume to value, prioritizing nutrient density over caloric density, Saluja says